Access Bio (XKRX:950130) Cash Flow for Lease Financing : ₩-6,432 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Access Bio Cash Flow for Lease Financing?

Access Bio's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was ₩-1,679 Mil. Access Bio's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-6,432 Mil.

Compared with last quarter (₩-1,170 Mil in Dec. 2023 ), Access Bio's Cash Flow for Lease Financing remained the same in Mar. 2024 (₩-1,679 Mil).

Access Bio Cash Flow for Lease Financing Historical Data

The historical data trend for Access Bio's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Cash Flow for Lease Financing Chart

Access Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Lease Financing

Get a 7-Day Free Trial

-747.36

-741.94

-2,240.77

-4,481.77

-6,332.68

Access Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-1,580.37	-1,764.33	-1,818.10	-1,169.89	-1,679.40

Access Bio Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,432 Mil.

Access Bio Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Access Bio's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Access Bio (XKRX:950130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Clyde Road, Suite A, Somerset, NJ, USA, 08873

Website

http://www.accessbio.net

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines